Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$406,422,135
+$42,411,946 QoQ
Shares Held
3,216,892
+23.2% QoQ
Ownership
0.259%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
#48
of 2,275 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Jun 30, 2026CallValue
$88,438,000
CallShares
700,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Holocene Advisors, LP holds $1,328,883,667 across 8 Drug Manufacturers - General names. GILD ranks #2 (30.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,429,349 | $460,653,157 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
3,216,892 | $406,422,135 | |
| 3 | LLY |
ELI LILLY & Co
|
176,517 | $211,719,802 | |
| 4 | NVS |
Novartis AG
|
1,037,332 | $162,570,671 | |
| 5 | MRK |
Merck & Co., Inc.
|
628,000 | $80,698,000 | |
| 6 | JNJ |
Johnson & Johnson
|
18,956 | $4,814,255 | |
| 7 | BIIB |
Biogen Inc.
|
4,793 | $1,035,575 | |
| 8 | ABBV |
AbbVie Inc.
|
3,855 | $970,072 |
All Filings in GILD
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,438,000 | 700,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $406,422,135 | 3,216,892 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $364,010,189 | 2,611,826 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $511,143,120 | 4,164,438 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $290,506,092 | 2,617,172 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $468,644,274 | 4,226,971 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $133,044,000 | 1,200,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $258,596,945 | 2,307,871 | Shares | Sole | 2025-05-15 | |
| 2022-03-31 | $1,528,637 | 25,713 | Shares | Sole | 2022-05-16 | |
| 2021-03-31 | $93,067,200 | 1,440,000 | Call | Sole | 2021-05-17 | |
| 2021-03-31 | $131,732,873 | 2,038,262 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $55,929,600 | 960,000 | Call | Sole | 2021-02-16 | |
| 2020-12-31 | $71,448,024 | 1,226,365 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $49,372,398 | 641,700 | Put | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||